Headlands Technologies LLC lifted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 6,982.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 25,993 shares of the company's stock after purchasing an additional 25,626 shares during the period. Headlands Technologies LLC's holdings in Acadia Healthcare were worth $788,000 at the end of the most recent quarter.
Several other hedge funds have also recently modified their holdings of ACHC. LPL Financial LLC raised its stake in shares of Acadia Healthcare by 5.4% in the fourth quarter. LPL Financial LLC now owns 55,830 shares of the company's stock worth $2,275,000 after purchasing an additional 2,869 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Acadia Healthcare by 21.4% in the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after buying an additional 3,248 shares in the last quarter. Quadrant Capital Group LLC lifted its holdings in Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after purchasing an additional 933 shares in the last quarter. FMR LLC boosted its holdings in Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Finally, Cerity Partners LLC boosted its stake in shares of Acadia Healthcare by 52.1% in the fourth quarter. Cerity Partners LLC now owns 50,060 shares of the company's stock worth $1,985,000 after acquiring an additional 17,138 shares during the last quarter.
Analysts Set New Price Targets
Several brokerages have recently weighed in on ACHC. KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Guggenheim lowered their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Cowen reiterated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Finally, Barclays lowered their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $44.75.
Check Out Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Stock Performance
ACHC traded up $1.26 during trading hours on Tuesday, hitting $20.33. 2,898,844 shares of the stock were exchanged, compared to its average volume of 2,201,541. The stock has a 50-day simple moving average of $22.13 and a 200-day simple moving average of $27.47. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $82.40. The stock has a market cap of $1.88 billion, a price-to-earnings ratio of 13.46, a price-to-earnings-growth ratio of 3.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same period in the previous year, the business posted $0.91 EPS. Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. Analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.